Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

BACKGROUND: Immunotherapy shows promise as a treatment option for various cancers. However, there is growing concern over potential complications from hepatitis B virus (HBV) reactivation after checkpoint blockade immunotherapy. Although most of the previous clinical trials on immune checkpoint inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Zhengzheng, Zhang, Jianyu, Chen, Wenjun, Zhou, Haiyan, Du, Di, Zhu, Kongcai, Chen, Hui, Meng, Jun, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Scoping Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515058/
https://www.ncbi.nlm.nih.gov/pubmed/37736699
http://dx.doi.org/10.1186/s40249-023-01128-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515058/
https://www.ncbi.nlm.nih.gov/pubmed/37736699
http://dx.doi.org/10.1186/s40249-023-01128-6

Ejemplares similares